Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma - PubMed (original) (raw)
Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma
K H Buetow et al. Proc Natl Acad Sci U S A. 1989 Nov.
Abstract
Primary hepatocellular carcinoma (PHC), epidemiologically associated with chronic hepatitis B virus (HBV) infection, has historically been felt to be caused by the activation or introduction of an oncogene. However, transforming sequences from human PHC have not been reproducibly isolated. In this paper, evidence is presented that suggests PHC may result instead from the loss of an anti-oncogene. Seven of 12 human primary liver tumors tested against a panel of restriction fragment length polymorphisms (RFLPs) demonstrated loss of constitutional heterozygosity for markers on chromosome 4. Tumor and nontumor liver tissue were typed for 11 chromosome 4 RFLPs. In addition, at least one RFLP on nine other chromosomes (1, 2, 6, 7, 9, 11, 13, 14, and 17) was tested for allelic loss. Seven of nine tumors constitutionally heterozygous for chromosome 4q markers showed allele loss in tumor tissue. Six of the seven samples were jointly informative for both 4p and 4q markers. Five of the six demonstrated loss for only 4q RFLPs. In one individual, in which two samples were taken from distant locations within the same tumor, both samples showed loss of the same alleles. Among the other chromosomes informative for allele loss, one tumor showed changes on 13q. No other changes were observed in RFLPs located on the eight other chromosomes tested. These results indicate that an anti-oncogene may be located on 4q and suggest a mechanism for PHC and other cancers seroepidemiologically related to virus infection. Liver cancer caused by chronic HBV infection or other environmental agents may be linked through genetic events responsible for the loss of a tumor suppressor locus (anti-oncogene) located on chromosome 4.
Similar articles
- [Loss of heterozygosity in hepatocellular carcinoma].
Takahashi K, Kudo J, Ishibashi H, Niho Y. Takahashi K, et al. Nihon Rinsho. 1993 Feb;51(2):370-4. Nihon Rinsho. 1993. PMID: 8096550 Review. Japanese. - Loss of somatic heterozygosity in hepatocellular carcinoma.
Walker GJ, Hayward NK, Falvey S, Cooksley WG. Walker GJ, et al. Cancer Res. 1991 Aug 15;51(16):4367-70. Cancer Res. 1991. PMID: 1678314 - Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma.
Zhang WD, Hirohashi S, Tsuda H, Shimosato Y, Yokota J, Terada M, Sugimura T. Zhang WD, et al. Jpn J Cancer Res. 1990 Feb;81(2):108-11. doi: 10.1111/j.1349-7006.1990.tb02534.x. Jpn J Cancer Res. 1990. PMID: 1970554 Free PMC article. - Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated alpha-fetoprotein production.
Yeh SH, Chen PJ, Lai MY, Chen DS. Yeh SH, et al. Gastroenterology. 1996 Jan;110(1):184-92. doi: 10.1053/gast.1996.v110.pm8536855. Gastroenterology. 1996. PMID: 8536855 - [Cytogenetic and molecular genetic alterations on chromosome 4q in human hepatocellular carcinoma].
Zhang HK, Wang HY, Xia JC. Zhang HK, et al. Ai Zheng. 2008 Sep;27(9):998-1005. Ai Zheng. 2008. PMID: 18799044 Review. Chinese.
Cited by
- Preemptive Homology-Directed DNA Repair Fosters Complex Genomic Rearrangements in Hepatocellular Carcinoma.
Sy SM, Guo Y, Lan Y, Ng H, Huen MS. Sy SM, et al. Transl Oncol. 2020 Sep;13(9):100796. doi: 10.1016/j.tranon.2020.100796. Epub 2020 May 22. Transl Oncol. 2020. PMID: 32450552 Free PMC article. - Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5.
Ai C, Ma G, Deng Y, Zheng Q, Gen Y, Li W, Li Y, Zu L, Zhou Q. Ai C, et al. Thorac Cancer. 2020 Mar;11(3):640-650. doi: 10.1111/1759-7714.13308. Epub 2020 Feb 5. Thorac Cancer. 2020. PMID: 32022430 Free PMC article. - Overexpression of SMARCA5 correlates with cell proliferation and migration in breast cancer.
Jin Q, Mao X, Li B, Guan S, Yao F, Jin F. Jin Q, et al. Tumour Biol. 2015 Mar;36(3):1895-902. doi: 10.1007/s13277-014-2791-2. Epub 2014 Nov 7. Tumour Biol. 2015. PMID: 25377162 - Genome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, China.
Qi LN, Li LQ, Chen YY, Chen ZH, Bai T, Xiang BD, Qin X, Xiao KY, Peng MH, Liu ZM, Liu TW, Qin X, Li S, Han ZG, Mo ZN, Santella RM, Winkler CA, O'Brien SJ, Peng T. Qi LN, et al. PLoS One. 2013 Dec 31;8(12):e83465. doi: 10.1371/journal.pone.0083465. eCollection 2013. PLoS One. 2013. PMID: 24391771 Free PMC article. - The cooperative effect of p53 and Rb in local nanotherapy in a rabbit VX2 model of hepatocellular carcinoma.
Dong S, Tang Q, Long M, Guan J, Ye L, Li G. Dong S, et al. Int J Nanomedicine. 2013;8:3757-68. doi: 10.2147/IJN.S51353. Epub 2013 Oct 2. Int J Nanomedicine. 2013. PMID: 24124364 Free PMC article.
References
- Cytogenet Cell Genet. 1986;42(1-2):36-41 - PubMed
- Hum Genet. 1988 Nov;80(3):274-6 - PubMed
- Nature. 1986 Oct 16-22;323(6089):643-6 - PubMed
- Nature. 1986 Nov 20-26;324(6094):276-9 - PubMed
- Am J Hum Genet. 1986 Dec;39(6):744-50 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical